Research Overview: Beligas Pharma – Tren-Test-Mast Short
Tren-Test-Mast Short 150mg/ml is a multi-compound anabolic steroid blend manufactured by Beligas Pharma, formulated specifically for advanced in-vitro laboratory research. This injectable solution combines three short-ester anabolic compounds: trenbolone acetate, testosterone propionate, and drostanolone propionate in a 150mg/ml concentration. The formulation enables researchers at Stroid UK Shop to investigate the synergistic interactions between these distinct anabolic agents within controlled laboratory environments. Each compound contributes unique pharmacological properties, making this blend valuable for comprehensive steroid research protocols examining multiple androgenic pathways simultaneously.
Research Applications
This tri-compound blend offers researchers the opportunity to examine complex anabolic interactions in laboratory settings. The trenbolone acetate component provides strong androgenic activity for investigating muscle protein synthesis pathways, while testosterone propionate serves as a reference androgen for comparative studies. Drostanolone propionate contributes anti-estrogenic properties, enabling researchers to study androgenic activity without estrogenic interference. Scientists studying anabolic steroid combinations can evaluate how these three compounds interact at the cellular level, examining receptor binding affinities, metabolic pathways, and tissue-specific responses. The short-ester formulation allows for rapid onset and clearance in research models, facilitating precise timing of experimental protocols and reducing washout periods between studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Concentration | 150mg/ml |
| Volume | 10ml vial |
| Compound Composition | Tri-blend formulation |
| Ester Types | Short-acting acetate/propionate |
| Solution Type | Oil-based injection |
| Manufacturer | Beligas Pharma |
| Storage Conditions | Room temperature, protect from light |
| Research Grade | Laboratory use only |
Researchers investigating metabolic pathways may also explore our SARM compounds for comparative androgen receptor studies, or examine peptide research chemicals for investigating alternative anabolic signalling mechanisms.
Regulatory Compliance
This Beligas Pharma Tren-Test-Mast Short 150mg/ml product is manufactured exclusively for in-vitro laboratory research applications. It is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, appropriate safety measures, and compliance with local regulations when handling this research chemical. All studies should be conducted by qualified personnel in approved research facilities with appropriate safety equipment and waste disposal procedures.
